Biofrontera (BFRI) Shares Outstanding (Diluted Average) (2021 - 2025)

Biofrontera's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $10.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) rose 84.4% year-over-year to $10.2 million; the TTM figure through Dec 2025 stood at $10.2 million (up 84.4% YoY), while the FY2025 annual figure was $10.2 million, up 84.4% from the prior year.
• Shares Outstanding (Diluted Average) was $10.2 million for Q4 2025 at Biofrontera, down from $10.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $17.1 million in Q1 2022 to a low of $902209.0 in Q2 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $5.7 million across 5 years, with a median of $5.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) tumbled 92.21% in 2023, then jumped 274.39% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $8.0 million in 2021, then sank by 86.79% to $1.1 million in 2022, then soared by 46.29% to $1.5 million in 2023, then jumped by 256.74% to $5.5 million in 2024, then jumped by 84.4% to $10.2 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $10.2 million (Q4 2025), $10.8 million (Q3 2025), and $9.4 million (Q2 2025), per Business Quant data.